1988
DOI: 10.1128/mcb.8.4.1857
|View full text |Cite
|
Sign up to set email alerts
|

Rejection of B16 melanoma induced by expression of a transfected major histocompatibility complex class I gene.

Abstract: Transfection of a functional major histocompatibility complex class I gene into certain tumor cells, induced by oncogenic viruses or chemical carcinogens, can effectively abrogate their tumorigenic activity. Since experimentally induced tumors possess strong tumor-specific transplantation antigens, expression of cell surface class I antigens may present the tumor cells to appropriate immune effector cells. Most spontaneously arising tumors do not possess tumor-specific transplantation antigens, and their tumor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
39
0

Year Published

1991
1991
2006
2006

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 62 publications
(41 citation statements)
references
References 30 publications
2
39
0
Order By: Relevance
“…Indeed, APC pulsed with B16-derived peptide epitopes are capable of eliciting specific CTL reactions directed against B16 melanoma both in vitro [24] and in vivo [25]. Furthermore, the transfection of B16 with the K b molecule converts it into a strongly immunogenic tumor in vivo [26] and renders it susceptible to rejection by immunocompetent mice [27]. Likewise, stably transfected B16 clones expressing the heat shock protein Hsp65, a "molecular chaperone," manifest significantly elevated levels of the MHC class I molecule and are more easily lysed by alloreactive CTL [28].…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, APC pulsed with B16-derived peptide epitopes are capable of eliciting specific CTL reactions directed against B16 melanoma both in vitro [24] and in vivo [25]. Furthermore, the transfection of B16 with the K b molecule converts it into a strongly immunogenic tumor in vivo [26] and renders it susceptible to rejection by immunocompetent mice [27]. Likewise, stably transfected B16 clones expressing the heat shock protein Hsp65, a "molecular chaperone," manifest significantly elevated levels of the MHC class I molecule and are more easily lysed by alloreactive CTL [28].…”
Section: Discussionmentioning
confidence: 99%
“…C57BL͞6 and BALB͞c mice, 8-to 12-wk-old, were obtained from Janvier (Laval, France). The Bosc23-packaging cell line (16) was from American Type Culture Collection, and the tumor cell lines MCA205 (17) and CL8.1 (18) were gifts from L. Zitvogel (Institut Gustave Roussy, Villejuif, France) and E. Gorelik (University of Pittsburgh, Pittsburgh, PA), respectively. Culture conditions were as indicated in the corresponding references.…”
Section: Methodsmentioning
confidence: 99%
“…BL6-8 and BL6-2 clones were also transfected with the p191-6 plasmid, which contains the entire H-2K agene cloned into the HindlII sites of pBR322 (Gorelik et al, 1991;Kim et al, 1994), or with the plasmids containing the genomic H-2D a or H-2L agene with the homogenous promoter (Kim et al, 1994). BL6-8 cells were also transfected with the pRSV plasmid containing both the 8"4 kb IAa k and 10 kb IAc~ k sequences of the class II H-2IA k gene (Tanaka et al, 1988). BL6-8 and BL6-2 ceils transfected with the class I or class [I MHC genes were cotransfected with the nea gene using Lipofectin reagent.…”
Section: Methodsmentioning
confidence: 99%
“…The BL6 melanoma subline was cloned and two clones, BL6-8 (H-2K b-, H-2Db+) and BL6-2 (H-2K b-, H-2D b-) were used as recipients of H-2 class I gene transfection. As detailed previously, BLb-8 or BL6-2 cells were transfected with the H-2K b genomic fragment subdoned into the SalI site of pTCF (Tanaka et aL, 1988;Gorelik et al, i991;Kim eta]., 1994). BL6-8 and BL6-2 clones were also transfected with the p191-6 plasmid, which contains the entire H-2K agene cloned into the HindlII sites of pBR322 (Gorelik et al, 1991;Kim et al, 1994), or with the plasmids containing the genomic H-2D a or H-2L agene with the homogenous promoter (Kim et al, 1994).…”
Section: Methodsmentioning
confidence: 99%